Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise

Evaluating emerging mutations in patients with acute myeloid leukaemia who relapsed while receiving gilteritinib therapy in the ADMIRAL trial

Simplifying molecular subtypes of metastatic gastric cancer

Association between tTMB and clinical outcomes with pembrolizumab alone in PD-L1-positive advanced NSCLC in KEYNOTE-010 and -042

VELIA/GOG-3005 trial: Veliparib for high-grade serous carcinoma of ovarian, fallopian tube, or primary peritoneal origin

Appraising an NTRK testing algorithm: When, what, how

Oncogenomics: From a surgical perspective

Using ctDNA to predict recurrence and response in colorectal cancer

Oncobox, RNA sequencing and molecular pathway analysis-base system for prescription of target drugs to advanced cancer patients

SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC

Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations